Search

everythinglearnresearchcommunity

for

Search:↓

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Oral calcitriol helped improve scleroderma and hair regrowth in a young woman.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Ritlecitinib is safe and may effectively treat alopecia areata.

New compounds show promise as nonsteroidal treatments for hair loss.

GD-23 reduces anxiety by relying on neurosteroid production.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Splitting non-scored tablets can lead to uneven drug distribution, posing risks.